Survival in Male Rett Mice Rises Significantly with Experimental Drugs (IMAGE)

Cold Spring Harbor Laboratory

Survival in Male Rett Mice Rises Significantly with Experimental Drugs

Caption

Relatively few boys born with MECP2 mutations leading to Rett syndrome survive. In male mice that model Rett (they lack the MECP2 gene), median survival rises from around 50 days in animals not treated with CSHL/Tonks Lab's experimental drugs, CPT157633 and UA0713, to around 75 days and 90 days, respectively, after a course of treatment with each of these compounds.

Credit

Tonks Lab, CSHL

Usage Restrictions

please give credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.